Cancer prevalence in Northern Europe: The EUROPREVAL study

Annals of Oncology

Volumn 14, Issue 6, 2003, Pages 946-957

  Moller T ^a   Anderson, H ^a   Aareleid, T ^b   Hakulinen, T ^c   Storm, H ^d   Tryggvadottir, L ^e   Corazziari, I ^f   Mugno, E ^g   Oberaigner, W ^h   Engholm, G ^d   Hedelin G ^k   Lefevre, H ^k   Mace Lesec'h, J ^k   Faivre, J ^k   Chaplain, G ^k   Carli, P M ^k   Arveux, P ^k   Esteve J ^h   Colonna, M ^k   Raverdy, N ^k   Jun, P ^k   Michaelis, J ^k   Ziegler, H ^k   Stegmaier, C ^k   Capocaccia, R ^k   De Angelis, R ^f   Francisci, S ^f   Hartley, S ^f   Valente, F ^f   Verdecchia, A ^f   Zappone, A ^f   Berrino, F ^g   Gatta, G ^g   Micheli, A ^g   Sant, M ^g   Crosignani, P ^k   Conti, E ^k   Vercelli, M ^k   Casella, C ^k   Puppo, A ^k   Federico, M ^k   Ponz De Leon, M ^k   De Lisi, V ^k   Zanetti, R ^k   Magnani, C ^k   Gafa L ^k   Falcini, F ^k   Paci, E ^k   Crocetti, E ^k   Guzzinati, S ^k   Rachtan, J ^k   Bielska Lasota, M ^k   Plesko, I ^k   Pompe Kirn, V ^k   Izarzugaza, I ^k   Izquierdo, A ^k   Martinez Garcia, C ^k   Garau, I ^k   Ardanaz, E ^k   Moreno, C ^k   Galceran, J ^k   Moreno, V ^k   Torhorst, J ^k   Bouchardy, C ^k   Lutz, J M ^k   Usel, M ^k   Dowd, J E ^k   Coebergh, J W W ^k   Janssen Heijnen, M ^k   Damuhis, R A M ^k   Black, R ^k   Harris, V ^k   Stockton, D ^k   Davies, T W ^k   Coleman, M P ^k   Harris, S ⁱ   Williams, E M I ^k   Forman, D ^k   Iddenden, R ^k   Quinn, M J ^k   Roche, M ^k   Smith, J ^k   Moller, H ^k   Silcocks, P ^k   Lawrence, G ^k   Hemmings, K ^j   more..

^a LUND UNIVERSITY   (Sweden)

^b Estonian Cancer Registry   (Estonia)

^c UNIVERSITY OF HELSINKI   (Finland)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e ICELANDIC CANCER REGISTRY   (Iceland)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h UNIVERSITÉ DE LYON   (France)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^j West Midlands Cancer Intelligence U   (United Kingdom)

^k West Midlands Can Intelligence Unit ^*

more..

Author keywords

Cancer; EUROPREVAL study; Incidence; Northern Europe; Prevalence; Survival

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EUROPE; FEMALE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RESOURCE ALLOCATION; SEX DIFFERENCE; STANDARDIZATION;

EID: 17744410787     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg255     Document Type: Article

References (34)

1. Capocaccia R, Colonna M, Corazziari I et al. Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol 2002; 13: 831-839.
2. Micheli A, Mugno E, Krogh V et al. Cancer prevalence in European registry areas. Ann Oncol 2002; 13: 840-865.
3. Statistics Yearbook of Sweden 2000. Stockholm: Statistics Sweden 2000.
4. Cancer Incidence in Denmark 1996. Sundhetsstatistikken 1999: 3. Köbenhavn: Danish National Board of Health 1999.
5. Cancer Incidence in Sweden 1997. Stockholm: The Cancer Registry, Centre for Epidemiology, The National Board of Health and Welfare 1999.
6. Hakama M, Hakulinen T, Teppo L, Saxén E. Incidence, mortality or prevalence as indicators of the cancer problem. Cancer 1975; 36: 2227-2231.
7. Adami H-O, Gunnarsson T, Sparén P, Eklund G. The prevalence of cancer in Sweden 1984. Acta Oncol 1989; 28: 463-470.
8. Hakulinen T, Kenward M, Luostarinen T et al. Cancer in Finland 1958-2008. Incidence, mortality and prevalence by county (Cancer Society of Finland Publication no. 42). Helsinki: Finnish Cancer Registry and Finnish Foundation for Cancer Research 1989.
9. Engeland A, Haldorsen T, Tretli S et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. Acta Pathol Microbiol Immunol Scand 1995; 103 (Suppl 49).
10. Thomson H, Rahu M, Aareleid T, Gornoi K. Cancer in Estonia 1968-1992 - Incidence, mortality, prevalence, survival. Tallinn: Institute of Experimental and Clinical Medicine 1996.
11. Verdeccia A, Micheli A, Colonna M, Izarzugaza M. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol 2002; 13: 1128-1139.
12. Parkin DM, Whelan SL, Ferlay J et al. (eds). Cancer Incidence in Five Continents - Volume VII. IARC Scientific Publication no. 143. Lyon: International Agency for Research on Cancer 1997.
13. Berrino F, Capocaccia R, Estève J et al. (eds). Survival of cancer patients in Europe: The EUROCARE II study. IARC Scientific Publication no. 151. Lyon: International Agency for Research on Cancer 1999.
14. Coebergh JW, Sant M, Berrino F, Verdeccia A (eds). Survival of adult cancer patients in Europe diagnosed from 1978-89: The EUROCARE II study. Eur J Cancer 1998; 34 Special Issue.
15. Cancer Incidence in Southern Sweden 1988-92. Lund: Oncological Centre 1994.
16. Health Statistics in the Nordic Countries 1997. København: Nordisk Medicinalstatistisk Komité 1999.
17. Lipand A, Kasmel A, Kivilo M et al. Health Behaviour Among Estonian Adult Population, spring 1990. Publication B1/1992. Helsinki: National Public Health Institute 1992.
18. Lewin F, Norell SE, Johansson H et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998; 82: 1367-1375.
19. Schildt EB, Eriksson M, Hardell L, Magnusson A. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer 1998; 77: 341-346.
20. Westerdahl J, Olsson H, Ingvar C et al. Southern travelling habits with special reference to tumour site in Swedish melanoma patients. Anti-cancer Res 1992; 12: 1539-1542.
21. Westerdahl J, Olsson H, Måsbäck A et al. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol 1994; 140: 691-699.
22. Hakama M. Trends in the incidence of cervical cancer in the Nordic countries. In Magnus K (ed): Trends in Cancer Incidence. Causes and Practical Implications. Washington, DC: Hemisphere 1982; 279-292.
23. Aareleid T, Pukkala E, Thomson H, Hakama M. Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population. Eur J Cancer 1993; 239: 745-749.
24. Hakama M, Pukkala E, Söderman B, Day N. Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen 1999; 6: 209-216.
25. Andersson I, Andrén L, Hildell J et al. Breast cancer screening with mammography: a population-based, randomized trial with mammography as the only screening mode. Radiology 1979; 132: 273-276.
26. Tretli S, Engeland A, Haldorsen T et al. Prostate cancer - look to Denmark? JNCI 1996; 88: 128.
27. Engeland A, Haldorsen T, Tretli S et al. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic cancer registries. Acta Pathol Microbiol Immunol Scand Suppl 1993; 38: 1-124.
28. Leinsalu M, Rahu M. Time trends in cancer mortality in Estonia, 1965-1989. Int J Cancer 1993; 53: 914-918.
29. Engeland A, Haldorsen T, Dickman P et al. Relative survival of cancer patients: A comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49-59.
30. Aareleid T, Rahu M. Cancer survival in Estonia 1978 to 1987. Cancer 1991; 68: 2088-2092.
31. Karjalainen S, Aareleid T, Hakulinen T et al. Survival of female breast cancer patients in Finland and in Estonia: stage at diagnosis important determinant of the difference between countries. Soc Sci Med 1989; 28: 233-238.
32. Lote K, Möller T, Nordman E et al. Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987. Acta Oncol 1991; 30: 555-561.
33. Nilsson B, Gustavson-Kadaka E, Hakulinen T et al. Cancer survival in Estonian migrants to Sweden. J Epidemiol Community Health 1997; 51: 418-423.
34. Stenbeck M, Rosén M, Sparén P. Causes of increasing cancer prevalence in Sweden. Lancet 1999; 354: 1093-1094.